ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Health-Related Quality of Life in the Pre-Transplant Candidate Low MELD for End-Stage Liver Disease (MELD) Score: A Pilot Study

R. Duke

Transplant Surgery, Northwestern Memorial Hospital, Chicago, IL

Meeting: 2013 American Transplant Congress

Abstract number: D1736

Cadaveric liver organ allocation is based on the model for end-stage liver disease (MELD) score. Those with low MELD scores (≤ 15) are considered to be low priority for liver transplantation. However, individuals with low MELD scores may experience an array of symptoms and health problems associated with chronic liver disease and therefore are at risk for low health related quality of life (HRQoL). No known published studies are available that have examined HRQoL specifically in the low MELD population. The aims of this pilot study were to 1) describe the HRQoL of the low MELD population and 2) identify clinical and demographic characteristics that were associated with HRQoL.

Methods: A single-center cross-sectional descriptive design was used to examine HRQoL in the cadaveric liver transplant candidate with MELD scores </= 15. For this pilot study, a convenience sample of fifty subjects was recruited from a large Midwestern metropolitan pre-liver transplant clinic. Variables to measure were selected based on the Wilson and Cleary Conceptual Model of HRQoL. Subjects completed written questionnaires examining quality of life, social support, depressive symptoms, health perception, biological function and liver disease symptoms. Clinical providers assessed physical functioning (Karnofsky Score).

Results: Descriptive, correlational and regression analysis were completed. The mean MELD score was 11.5, which suggests that overall; subjects had a low 3 month mortality rate. Subjects rated their HRQoL moderately high with a mean score of 20 (range 0-30). The MELD score was not associated with overall HRQoL. Depressive symptoms (CES-D) (B=-0.592, p=0.000) and perceived social support (B=0.202, p=0.012) independently predicted HRQoL. The regression model explained 78% of the variance in HRQoL (adjusted R2=0.787, F (8, 41) =23.58, p=0.000).

Conclusions: This population has limited likelihood for transplantation in the current prioritization system. The most significant predictors of HRQoL were depressive symptoms and level of social support. Although further longitudinal research is needed with a larger sample size, these findings have implications for health care providers. Health care providers can screen for depressive symptoms more proactively. Social support was also predictive and while, the health care team cannot modify it, support groups and resources can provide additional assistance and help to this population.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Duke R. Health-Related Quality of Life in the Pre-Transplant Candidate Low MELD for End-Stage Liver Disease (MELD) Score: A Pilot Study [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/health-related-quality-of-life-in-the-pre-transplant-candidate-low-meld-for-end-stage-liver-disease-meld-score-a-pilot-study/. Accessed June 6, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences